Genes & genomicsHumansBreast NeoplasmsFemalebeta-AlanineBiomarkers
A prognostic model for basal-like breast cancer based on beta-alanine metabolism genes: EHHADH as a potential biomarker and target for drug screening.
Xianjie Cheng, Birong Liu, Hong Lou, Fei Guo, Qiangsheng Xiao
Published: 202510.1007/s13258-025-01674-3
Abstract
BACKGROUND: The high heterogeneity of basal-like breast cancer (BLBC) impedes early diagnosis and accurate prognosis. Beta-alanine, a non-essential amino acid involved in various metabolic pathways, accumulates in BLBC cells and may exacerbate tumor…
Preview only. Read the full abstract at the source